SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 63.91 |
Enterprise Value ($M) | 87.79 |
Book Value ($M) | -20.87 |
Book Value / Share | -0.45 |
Price / Book | -3.06 |
NCAV ($M) | -35.34 |
NCAV / Share | -0.77 |
Price / NCAV | -1.81 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.63 |
Return on Assets (ROA) | -0.30 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.21 |
Current Ratio | 1.34 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 63.30 |
Assets | 77.77 |
Liabilities | 98.64 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 81.76 |
Operating Income | -8.66 |
Net Income | -23.96 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -5.68 |
Cash from Investing | 1.11 |
Cash from Financing | 14.78 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Nantahala Capital Management, LLC | 5.80 | ||
13G/A | Hirschman Orin | 8.10 | -10.36 | |
13D | Soleus Capital Master Fund, L.P. | 10.50 | ||
13D | Investissement Quebec | 19.90 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
7,265 | 51,474 | 14.11 | |
3,860 | 26,336 | 14.66 | |
3,649 | 8,931 | 40.86 | |
10,431 | 18,585 | 56.13 | |
(click for more detail) |
Similar Companies | |
---|---|
TFFP – TFF Pharmaceuticals, Inc. | TGTX – TG Therapeutics, Inc. |
THAR – Tharimmune, Inc. | TIL – Instil Bio, Inc. |
TLSA – Tiziana Life Sciences Ltd |
Financial data and stock pages provided by
Fintel.io